Although there's no evidence people immunized with either vaccine have less protection against the variants, both companies said they have started looking at ways to account for evolving mutations.Especially worrying is the B.1.351 variant first seen in South Africa. It carries a mutation that helps it elude the body's immune response to infection. The B.1.1.
"It's going to be on the order of a few hundred individuals in terms of size and we'd expect that that might take a few months," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said during a call with reporters on Monday.Both Moderna's and Pfizer's vaccine use a new technology using messenger RNA or mRNA that simply requires a genetic code.
Police officer tried to hit me. An act of violence during today's protest.
😭
Since these variants apparently cause more severe outcomes, are more contagious, and occur at a faster transmission rate, I am curious as to whether boosters can keep ahead of mutations. I can foresee a need a need for annual vaccinations.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.